INSIGHTS ON SOLID DOSE MANUFACTURING

• GLP-1 OSD Chemical Synthesis Workflow

  Enhance containment and process reliability in oral GLP-1 synthesis. Discover how integrated single-use assemblies and automated fluidics safeguard chemical purity during scale-up.

• The Importance Of Polymorph Screenings

  Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.

• Morpho Shreveport Facility: Tablet, Capsule And Packaging Manufacturing Capabilities

  Food and supplement manufacturing in Louisiana spans blending, compression, film coating, encapsulation, and several packaging formats, backed by dedicated quality control testing from raw materials through finished product.

• The Future Of Sustainable Amorphous Dispersion Development

  Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.

• Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development

  7/23/2026

  Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

• Delivering API-In-Capsule For Potent, Low-Flow Compounds

  9/9/2026

  See how an automated capsule-filling approach addressed poor-flow APIs, improved operator safety, and supported fast scale-up for clinical supply needs.

• Precision In Miniature: Optimizing Multiparticulate Formulations For Pediatric Oncology

  9/9/2026

  When an oral liquid formulation of crizotinib failed pediatric trials due to intolerable taste and irritation, a multiparticulate approach offered a technically demanding but viable path forward.

• HPAPIS Production: "Where Micrograms Matters"

  4/13/2026

  In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

• Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling

  7/15/2026

  Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.